| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918667 | Radiotherapy and Oncology | 2012 | 6 Pages |
Abstract
We found and validated that the TGFβ1 rs1800469:C-509T genotype is associated with severe RE. This response marker may be used for guiding therapy intensity in an individual patient, which would further the goal of individualized therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jose Luis Lopez Guerra, Daniel Gomez, Qingyi Wei, Zhengshen Liu, Li-E Wang, Xianglin Yuan, Yan Zhuang, Ritusko Komaki, Zhongxing Liao,
